-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Tcr2 Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2022.
- Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the quarter ending March 31, 2023 was -1.03 USD/shares, a 35.5% decline year-over-year.
- Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2023 was -4.2 USD/shares.
- Tcr2 Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -3.93 USD/shares, a 49.4% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)